Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Shattuck Labs, Inc. (STTK)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 41,740,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Shattuck Labs is a clinical-stage biopharmaceutical company engaged in developing dual-sided fusion proteins, including its Agonist Redirected Checkpoint and GADLEN™ platforms, as classes of biologic medicines capable of multifunctional activity with applications in oncology and inflammatory diseases. Co.'s product candidate SL-172154, which is in Phase 1 clinical trial for the treatment of patients with ovarian cancer. Co.'s second product candidate, SL-279252, which is developed to inhibit the PD-1/PD-L1 interaction and activate the OX40 costimulatory receptor and is in Phase 1 clinical trial in patients with solid tumors and lymphoma. Co. has several compounds in preclinical development.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 16,004 41,004 41,004 41,004
Total Sell Value $168,522 $418,522 $418,522 $418,522
Total People Sold 1 2 2 2
Total Sell Transactions 1 2 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 133
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Green Jeremy Director   –       •       •   2024-03-28 4 D $0.00 $0 I/I (4,425) 5,615,489     -
   Stout Stephen See Remarks   •       –      –    2024-03-06 4 AS $10.53 $168,522 D/D (16,004) 74,437     -
   Stout Stephen See Remarks   •       –      –    2024-03-06 4 OE $3.51 $39,380 D/D 11,109 85,791     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2024-01-30 4 D $9.99 $22,877 D/D (2,290) 79,427     -
   Stout Stephen See Remarks   •       –      –    2024-01-30 4 D $9.99 $5,924 D/D (593) 79,332     -
   Deyoung Casi Chief Business Officer   •       –      –    2024-01-30 4 D $9.99 $20,060 D/D (2,008) 89,489     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2024-01-30 4 D $9.99 $29,171 D/D (2,920) 216,360     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 33,425 81,717     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2024-01-10 4 D $10.09 $30,139 D/D (2,987) 219,280     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 46,475 222,267     -
   Deyoung Casi Chief Business Officer   •       –      –    2024-01-10 4 D $10.09 $15,972 D/D (1,583) 91,497     -
   Deyoung Casi Chief Business Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 46,200 93,080     -
   Neill Andrew R Chief Financial Officer   •       –      –    2024-01-10 4 S $10.00 $250,000 D/D (25,000) 173,446     -
   Neill Andrew R Chief Financial Officer   •       –      –    2024-01-10 4 D $10.09 $24,922 D/D (2,470) 198,446     -
   Neill Andrew R Chief Financial Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 56,500 200,916     -
   Stout Stephen See Remarks   •       –      –    2024-01-10 4 A $0.00 $0 D/D 49,050 79,925     -
   Stout Stephen See Remarks   •       –      –    2023-05-10 4 A $0.00 $0 D/D 15,900 30,875     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2023-01-25 4 A $0.00 $0 D/D 37,875 175,792     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2023-01-25 4 A $0.00 $0 D/D 26,100 47,092     -
   Neill Andrew R Chief Financial Officer   •       –      –    2023-01-25 4 A $0.00 $0 D/D 34,925 144,416     -
   Deyoung Casi Chief Business Officer   •       –      –    2023-01-25 4 A $0.00 $0 D/D 27,100 46,880     -
   Thomson Erin Ator General Counsel   •       –      –    2023-01-25 4 A $0.00 $0 D/D 24,125 103,209     -
   Deyoung Casi Chief Business Officer   •       –      –    2023-01-10 4 D $3.03 $4,796 D/D (1,583) 19,780     -
   Shukla Abhinav A. Chief Technical Officer   •       –      –    2023-01-10 4 D $3.03 $5,857 D/D (1,933) 20,992     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2023-01-10 4 D $3.03 $9,051 D/D (2,987) 137,917     -
  133 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us